| Surgery as a Treatment for Medically Intractable Epilepsy (NCT01273129) | National Institute of Neurological Disorders and Stroke (NINDS) | 2011-03-21 |
| Modified Atkins Diet Treatment for Adults With Drug-resistant Epilepsy (NCT01311440) | Oslo University Hospital | 2011-03-01 |
| PuLsE 2-Observational Long-Term Effectiveness Follow-Up Study of PuLsE 1 (NCT01281280) | Cyberonics, Inc. | 2011-03-01 |
| Prospective Study of Comparison Between the Modified Atkins Diet and Classic Ketogenic Diet for Intractable Childhood Epilepsy (NCT02100501) | Yonsei University | 2011-03-01 |
| Seizure Detection and Automatic Magnet Mode Performance Study (NCT01325623) | Cyberonics, Inc. | 2011-03-01 |
| Long-Term Safety Study of Retigabine Immediate Release (IR) as Adjunctive Therapy in the Treatment of Adults With Partial-Onset Seizures (POS) (NCT01336621) | GlaxoSmithKline | 2011-02-21 |
| An Open Label, Randomised, Repeat Dose Study to Assess the Pharmacokinetic Performance of Five Ezogabine/Retigabine Modified Release (MR) Formulations at Steady State Compared to the Immediate Release (IR) Formulation. (NCT01332513) | GlaxoSmithKline | 2011-02-10 |
| A Study of Diazepam After Intranasal and Intravenous Administration to Healthy Volunteers (NCT01364558) | University of Minnesota | 2011-02-01 |
| A Study of Levetiracetam in Japanese Pediatric Patients With Generalized Tonic-clonic Seizures (NCT01292837) | UCB Japan Co. Ltd. | 2011-02-01 |
| Functional Link Between Hippocampal and Vestibular Systems: a Pilot Study in Epilepsy Surgery (NCT01285921) | Assistance Publique - Hôpitaux de Paris | 2011-02-01 |
| Risk of Urinary Retention With Retigabine (NCT01462656) | GlaxoSmithKline | 2011-02-01 |
| Catamenial Epilepsy Treatment (NCT01299870) | Timothy Welty, PharmD | 2011-02-01 |
| Bioequivalence Study of 300 mg Gabapentin (NCT01738893) | GlaxoSmithKline | 2011-01-14 |
| Evaluation of the Pharmacokinetics, Safety, and Tolerability of TPM XR as Adjunctive Therapy in Pediatric Subjects With Epilepsy (NCT01284530) | Supernus Pharmaceuticals, Inc. | 2011-01-01 |
| Observational Study in Infants Who Are Prescribed Treatment With Keppra® (Levetiracetam) Oral Solution (NCT01210690) | UCB Pharma | 2011-01-01 |
| Vagus Nerve Stimulation Clinical Outcomes Measured Prospectively in Patients Stimulated (NCT01281293) | Cyberonics, Inc. | 2011-01-01 |
| Multimodal Functional Neuroimaging in Epilepsy Patients (NCT02132507) | University of Minnesota | 2011-01-01 |
| The Effect of Anti-epileptic Drugs on Mitochondrial Activity (NCT01218321) | Hadassah Medical Organization | 2011-01-01 |
| Efficacy and Safety of Eslicarbazepine Acetate as Monotherapy for Patients With Newly Diagnosed Partial-onset Seizures (NCT01162460) | Bial - Portela C S.A. | 2010-12-01 |
| Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures (NCT01261325) | UCB Pharma | 2010-12-01 |
| Prevention of Photoparoxysmal Abnormalities by Mozart K448 (NCT01363154) | Medical University of South Carolina | 2010-11-01 |
| Evaluation Phenobarbital as Adjunctive Therapy in Participants With Partial Onset Seizures (NCT01284556) | West-Ward Pharmaceutical | 2010-11-01 |
| Women With Epilepsy: Pregnancy Outcomes and Deliveries (NCT01259310) | NYU Langone Health | 2010-11-01 |
| Efficacy of Fluoxetine Against Seizure-induced Central Apneas (NCT02569970) | Hospices Civils de Lyon | 2010-11-01 |
| Genetics of Epilepsy and Related Disorders (NCT01858285) | Boston Children's Hospital | 2010-11-01 |
| Levetiracetam Versus Topiramate as Adjunctive Therapy to Evaluate Efficacy and Safety in Subjects With Refractory Partial Onset Seizures (NCT01229735) | UCB Korea Co., Ltd. | 2010-11-01 |
| Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures (NCT01191086) | Upsher-Smith Laboratories | 2010-10-01 |
| A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures (Except Partial Seizures Evolving to Secondarily Generalized Seizures) (NCT01228747) | UCB Japan Co. Ltd. | 2010-10-01 |
| Comparative Bioavailability Study of Two Different Sources of Eslicarbazepine Acetate (NCT02284880) | Bial - Portela C S.A. | 2010-10-01 |
| Does Valproate Increase Levels of Folate Receptor Autoantibodies in Women? (NCT01231646) | Northwell Health | 2010-10-01 |
| Connectivity Analysis for Investigation of Auditory Impairment in Epilepsy (NCT01212068) | National Institute on Deafness and Other Communication Disorders (NIDCD) | 2010-09-10 |
| A Study With an Open-label Extension Phase to Evaluate the Effect of Perampanel (E2007) on Cognition, Growth, Safety, Tolerability, and Pharmacokinetics in Adolescents (NCT01161524) | Eisai Inc. | 2010-09-01 |
| Systematic Review: Retigabine for Adjunctive Therapy in Partial Epilepsy (NCT01587339) | GlaxoSmithKline | 2010-09-01 |
| A Study to Evaluate the Efficacy and Safety of Add-on Therapy of Wuling Capsule in Epilepsy Patients With Depression (NCT01125241) | Shanghai Zhongshan Hospital | 2010-09-01 |
| Open-Label Extension Study to Assess the Safety and Seizure Frequency Associated With Lacosamide for Primary Generalized Tonic-Clonic Seizures in Subjects With Epilepsy (NCT01118962) | UCB BIOSCIENCES, Inc. | 2010-08-01 |
| Heart Rate Changes in Subjects With Epilepsy (NCT01202669) | Cyberonics, Inc. | 2010-08-01 |
| Exploration of Genotype Based Personalized Prescription of Valproate Sodium in Anti-epileptic Treatment (NCT01172626) | Sun Yat-sen University | 2010-08-01 |
| Trial of Melatonin to Improve Sleep in Children With Epilepsy and Neurodevelopmental Disabilities (NCT01161108) | The Hospital for Sick Children | 2010-07-01 |
| Remote Tracking of Epilepsy Patients (NCT01130649) | University of California, San Francisco | 2010-07-01 |
| Clinical-genetic Investigations in Children With Early Infantile Epilepsies (NCT01357707) | Markus Schuelke, M.D. | 2010-07-01 |
| Efficacy and Safety of the Use of Memantine for Preserving Cognition in Adult Patients With Epilepsy (NCT00986115) | University of California, Davis | 2010-07-01 |
| Study of Retigabine Immediate Release as Adjunctive Therapy to Specified Monotherapy Antiepileptic Treatments in Adults With Partial-Onset Seizures (NCT01227902) | GlaxoSmithKline | 2010-07-01 |
| Study of Verapamil in Refractory Epilepsy (NCT01126307) | University Health Network, Toronto | 2010-06-01 |
| A Conversion Study of Immediate Release (IR) and Modified Release (MR) Forms of Topiramate (TPM) (NCT01114854) | Supernus Pharmaceuticals, Inc. | 2010-06-01 |
| Cancer in Patients With Gabapentin (GPRD) (NCT01236053) | GlaxoSmithKline | 2010-06-01 |
| Safety & Efficacy of Eslicarbazepine Monotherapy in Sub.w/Partial Epilepsy Not Well Controlled by Current Antiepileptic (NCT01091662) | Sumitomo Pharma America, Inc. | 2010-06-01 |
| Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy (NCT01128959) | Lundbeck LLC | 2010-06-01 |
| Cognitive and Behavioral Effects of Lacosamide (NCT01175954) | Evan Fertig | 2010-05-01 |
| Clinical and Economic Burden of Uncontrolled Epilepsy: Analyses From a Medicaid Database and a Private Health Plan Database (NCT01390909) | GlaxoSmithKline | 2010-05-01 |
| Study to Evaluate the Safety and Effectiveness of USL255 in Patients With Refractory Partial-onset Seizures (NCT01142193) | Upsher-Smith Laboratories | 2010-05-01 |
| Open-Label Study to Assess Lacosamide Safety as Add-on Therapy for Primary Generalized Tonic-Clonic Seizures in Subjects With Epilepsy (NCT01118949) | UCB BIOSCIENCES, Inc. | 2010-05-01 |
| Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients (NCT01422720) | Bial - Portela C S.A. | 2010-04-01 |
| IV Lacosamide: The Safety of Intravenous Lacosamide (NCT01981447) | Le Bonheur Children's Hospital | 2010-04-01 |
| Gabapentin and Risk of Pancreatic Cancer and Renal Cancer (GPRD) (NCT01138124) | GlaxoSmithKline | 2010-03-01 |
| Seizure Advisory System Feasibility Study (NCT01043406) | NeuroVista Corporation | 2010-03-01 |
| Epilepsy Birth Control Registry (NCT01097837) | Neuroendocrine Associates P.C. | 2010-03-01 |
| Cerebral Metabolic Changes Associated With Thalamic Stimulation (NCT01141764) | The Hospital for Sick Children | 2010-03-01 |
| The Safety of Intravenous Lacosamide (NCT00832884) | Le Bonheur Children's Hospital | 2010-03-01 |
| Scalp Nerve Blocks for Post-Craniotomy Pain (NCT00972790) | Unity Health Toronto | 2010-03-01 |
| ESOXC-ER Efficacy and Safety of an Extended Release (ER) Formulation of Oxcarbazepine (Apydan Extent) in Epileptic Patients (NCT01086501) | Desitin Arzneimittel GmbH | 2010-02-01 |
| Everolimus (RAD001) Therapy for Epilepsy in Patients With Tuberous Sclerosis Complex (TSC) (NCT01070316) | Children's Hospital Medical Center, Cincinnati | 2010-01-01 |
| Neurocysticercosis: Combined Treatment With Praziquantel (PZQ) and Albendazole (ABZ) (NCT00441285) | Universidad Peruana Cayetano Heredia | 2010-01-01 |
| Assessment of Suicidality in Epilepsy - Rating Tools (NCT01085461) | The Epilepsy Study Consortium | 2010-01-01 |
| An Open Label Study of Levetiracetam in Japanese Pediatric Patients With Partial Seizures (NCT01063764) | UCB Japan Co. Ltd. | 2010-01-01 |
| An Open-Label Study to Determine Safety , Tolerability, and Efficacy of Oral Lacosamide in Children With Epilepsy (NCT00938912) | UCB BIOSCIENCES, Inc. | 2009-12-09 |
| A Multicenter, Open-Label Study To Investigate The Safety And Pharmacokinetics Of Lacosamide In Children With Partial Seizures (NCT00938431) | UCB Pharma | 2009-11-01 |
| Does Pregabalin Improve Symptoms of Anxiety in Patients With Epilepsy? A Comparison With Sertraline (NCT01309074) | Rush University Medical Center | 2009-11-01 |
| Preventing Depression in People With Epilepsy: an Extension of Project UPLIFT (NCT01941706) | Emory University | 2009-10-01 |
| Microelectrodes in Epilepsy (NCT05200455) | Dartmouth-Hitchcock Medical Center | 2009-09-18 |
| Assessment of Service and Hearing Dogs (NCT03270592) | Linkoeping University | 2009-09-17 |
| A Study to Investigate the Effect of ICA-105665 in Photosensitive Epilepsy Patients (NCT00979004) | Pfizer | 2009-09-01 |
| Clinical Study With Lyrica In Patients Suffering From Epilepsy (NCT00922987) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2009-09-01 |
| Study Evaluating the Pharmacokinetics of Keppra Extended Release (XR) in Children and Adults With Epilepsy (NCT00961441) | UCB BIOSCIENCES, Inc. | 2009-09-01 |
| Target Planning for Placement of DBS-electrodes and Follow-up of the Clinical Efficacy of Stimulation (NCT01210781) | University of Zurich | 2009-09-01 |
| Radiosurgery or Open Surgery for Epilepsy Trial (NCT00860145) | University of California, San Francisco | 2009-09-01 |
| Eslicarbazepine Acetate Monotherapy Long Term Study (NCT00910247) | Sumitomo Pharma America, Inc. | 2009-08-01 |
| Transcutaneous Non-invasive Stimulation of the Vagus Nerve for the Treatment of Difficult-to-treat Epilepsy (NCT01178437) | cerbomed GmbH | 2009-08-01 |
| A Pilot Study to Evaluate Efficacy and Safety of Clevidipine in Neurosurgical Patients (NCT00952081) | NYU Langone Health | 2009-07-01 |
| Pharmacokinetic Interaction Study Between Eslicarbazepine Acetate and Carbamazepine (NCT02284854) | Bial - Portela C S.A. | 2009-07-01 |
| GABA/Glutamate Balance in Temporal Lobe Epilepsy With and Without Major Depression (NCT00931619) | National Institute of Neurological Disorders and Stroke (NINDS) | 2009-06-29 |
| Cartography of Functional and Epileptic Cerebral Areas by Functional MRI and Electroencephalography in Epileptic Patients Before and After Surgery (NCT03102957) | University Hospital, Grenoble | 2009-06-17 |
| Long Term Study of the Safety of OXC XR as in Pediatric Epilepsy Subjects (NCT00918424) | Supernus Pharmaceuticals, Inc. | 2009-06-01 |
| Effect of Repeated Administration of Eslicarbazepine Acetate on the Pharmacokinetics of Simvastatin in Healthy Subjects (NCT00987558) | Bial - Portela C S.A. | 2009-06-01 |
| Spectral Dynamic Imaging of Cognitive Functions in Epileptic Patients Explored Stereoelectroencephalography (NCT02869698) | University Hospital, Grenoble | 2009-06-01 |
| Birth Defects Associated With Exposure to Lamotrigine in Pregnancy (EUROCAT) (NCT01055327) | GlaxoSmithKline | 2009-05-01 |
| Topiramate Treatment for Patients With Epilepsy and Learning Disability : A Prospective Observational Study (NCT00956696) | Chinese University of Hong Kong | 2009-05-01 |
| The Study of NPC-06 - Investigation of Safety, Efficacy and Pharmacokinetics of Fosphenytoin (NCT00908453) | Nobelpharma | 2009-05-01 |
| Modified Atkins Diet in Children and Adolescents With Drug-resistant Epilepsy (NCT01278966) | Oslo University Hospital | 2009-05-01 |
| Special Drug Use Investigation for LAMICTAL® (Long Term) (NCT01863602) | GlaxoSmithKline | 2009-04-01 |
| Assess Specific Kinds of Children Challenges for Neurologic Devices Study (NCT01191307) | Carlos Pena, PhD, MS | 2009-03-01 |
| Efficacy of BGG492 in Individuals With Refractory Partial Seizures Undergoing Inpatient Evaluation for Epilepsy Surgery (NCT00887861) | Novartis | 2009-03-01 |
| Standardized Educational Plan for Epilepsy Patients With Comorbidities (NCT01804322) | San Gerardo Hospital | 2009-02-01 |
| Does Memantine Improve Verbal Memory Task Performance in Subjects With Partial Epilepsy and Memory Dysfunction? (NCT01054599) | American Academy of Neurology | 2009-01-01 |
| Stimulation of the Anterior Nucleus of the Thalamus for Epilepsy - Recruitment Stimulation of the Anterior Nucleus of the Thalamus for Epilepsy - Recruitment Rhythm (NCT00772421) | MedtronicNeuro | 2009-01-01 |
| A Drug Interaction Study of Valproic Acid and Single-dose Paliperidone Extended-Release (ER) in Healthy Men (NCT01060228) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2009-01-01 |
| Drug Use Investigation for LAMICTAL (NCT01376180) | GlaxoSmithKline | 2008-12-01 |
| P-glycoprotein Inhibition as Adjunct Treatment for Medically Refractory Epilepsy. (NCT00524134) | Columbia University | 2008-12-01 |
| A Study to Evaluate the Safety and Tolerability and Explore the Efficacy of Zonisamide as add-on Therapy in Elderly Patients With Refractory Partial Seizures (NCT01546688) | Eisai Limited | 2008-11-01 |
| To Evaluate the Pharmacokinetics and Safety/Tolerability of Lacosamide in 3 Dosages in Healthy Male Korean Subjects (NCT01450111) | UCB Pharma | 2008-11-01 |
| Assessing The Long-Term Safety And To Explore The Long-Term Efficacy Of Zonisamide As Monotherapy In Newly Diagnosed Partial Seizures (NCT00848549) | Eisai Inc. | 2008-10-01 |